CAR-T NKR-2 Therapy

July 5, 2017July 5, 2017

Celyad’s CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer

News

New data from the Phase 1 THINK clinical trial (NCT03018405) show that two metastatic colorectal cancer (mCRC) patients whose disease progressed following at least two prior therapies had stabilized the ... Read more

May 3, 2017

First Ovarian Cancer Patient Dosed in Phase 1 Trial of Solid-Tumor Therapy Celyad

News

The U.S. arm of a Phase 1 clinical trial of Celyad as a solid-tumor treatment has kicked off with the dosing of the first ovarian cancer patient at the Roswell Park Cancer Institute in ... Read more